lobbying_activities: 2681020

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2681020	6c003377-d233-4902-8737-f21fd1db5463	Q3	TODD STRATEGY GROUP	401103321	ALKERMES, INC.	2021	third_quarter	PHA	Prescription drug pricing.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2021-10-15T08:06:34.127000-04:00